Solid Biosciences (NASDAQ:SLDB) Price Target Cut to $10.00 by Analysts at Barclays
Solid Biosciences (NASDAQ:SLDB – Get Free Report) had its target price reduced by Barclays from $15.00 to $10.00 in a research note issued on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Barclays‘s target price indicates a potential upside of 261.01% from the stock’s previous close. Other research analysts have also […]
